Clinical Research Advantage, Inc./Manning Family Care, LLC — Kansas City, Missouri

Clinical Research Advantage, Inc./Manning Family Care, LLC is a clinical research site located in Kansas City, Missouri, United States 64133.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Clinical Research Advantage, Inc./Manning Family Care, LLC has participated in 1 clinical trials.

Therapeutic areas: Arthritis, Rheumatoid.

Sponsors: Pfizer's Upjohn has merged with Mylan to form Viatris Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Kansas City

Browse all research sites in Missouri · View every site in Kansas City

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Research Advantage, Inc./Manning Family Care, LLC?

Clinical Research Advantage, Inc./Manning Family Care, LLC has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Research Advantage, Inc./Manning Family Care, LLC conducted?

Clinical Research Advantage, Inc./Manning Family Care, LLC has 1 clinical trials on record. Their work covers Arthritis, Rheumatoid.

Is Clinical Research Advantage, Inc./Manning Family Care, LLC accredited by Crixeo Clinical Trials?

Clinical Research Advantage, Inc./Manning Family Care, LLC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clinical Research Advantage, Inc./Manning Family Care, LLC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.